Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of finasteride plus low-dose dutasteride vs finasteride alone in male androgenetic alopecia
TCTR20260430003Phase 3Completed
- Sponsor
- Faculty of Medicine, Srinakharinwirot University
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of finasteride, dutasteride in androgenetic alopecia (AGA), sponsored by Faculty of Medicine, Srinakharinwirot University. Started May 2023; status: completed.
02
Drugs
finasteridedutasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on TCTR20260430003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260430003.